Oral cholera vaccine coverage, barriers to vaccination, and adverse events following vaccination, Haiti, 2013

Emerging Infectious Diseases

Volumn 21, Issue 6, 2015, Pages 984-991

  Tohme, Rania A ^a   François, Jeannot ^b   Wannemuehler, Kathleen ^a   Iyengar, Preetha ^a   Dismer, Amber ^a   Adrien, Paul ^b   Hyde, Terri B ^a   Marston, Barbara J ^a   Date, Kashmira ^a   Mintz, Eric ^a   Katz, Mark A ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b Ministry of Public Health and Population   (Haïti)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLERA VACCINE;

ARTICLE; AWARENESS; CHILD; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HEALTH CARE PLANNING; HEALTH CARE SURVEY; HOUSEHOLD; HUMAN; INFANT; INTERVENTION STUDY; INTERVIEW; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; QUESTIONNAIRE; SCHOOL CHILD; VACCINATION; WORLD HEALTH ORGANIZATION; CHOLERA; FAMILY SIZE; HAITI; HEALTH SURVEY; HISTORY; IMMUNOLOGY; ORAL DRUG ADMINISTRATION;

ADMINISTRATION, ORAL; CHOLERA; CHOLERA VACCINES; FAMILY CHARACTERISTICS; FEMALE; HAITI; HISTORY, 21ST CENTURY; HUMANS; MALE; PUBLIC HEALTH SURVEILLANCE; VACCINATION;

EID: 84981718825     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid2106.141797     Document Type: Article

References (33)

1. World Health Organization. Cholera, 2010. Wkly Epidemiol Rec. 2011;86:325-39.
2. World Health Organization. Cholera, 2011. Wkly Epidemiol Rec. 2012;87:289-304.
3. World Health Organization. Cholera, 2012. Wkly Epidemiol Rec. 2013;88:321-34.
4. World Health Organization. Cholera, 2013. Wkly Epidemiol Rec. 2014;89:345-56.
5. Ministry of Public Health and Population. National plan for the elimination of cholera in Haiti, 2013-2022 [cited 2013 Jun 8]. http://reliefweb.int/sites/reliefweb.int/files/resources/National%20Plan%20for%20the%20Elimination%20of%20Cholera%20in%20Haiti%202013-2022.pdf
6. Republic of Haiti. National plan for the elimination of cholera in Haiti, 2013-2022: short term plan 2013-2015 [cited 2015 Jan 6]. http://www.paho.org/hq/index.php?option=com_docman&task=doc_view&gid=20578&Itemid=270&lang=en
7. World Health Organization. 64th World Health Assembly. Cholera: mechanism for control and prevention resolution, 24 May 2011 [cited 2013 Jun 8]. http://www.who.int/cholera/technical/Resolution_CholeraA64_R15-en.pdf
8. Legros D, Paquet C, Perea W, Marty I, Mugisha NK, Royer H, et al. Mass vaccination with a two-dose oral cholera vaccine in a refugee camp. Bull World Health Organ. 1999;77:837-42.
9. Cavailler P, Lucas M, Perroud V, McChesney M, Ampuero S, Guerin PJ, et al. Feasibility of a mass vaccination campaign using a two-dose oral cholera vaccine in an urban cholera-endemic setting in Mozambique. Vaccine. 2006;24:4890-5. http://dx.doi.org/10.1016/j.vaccine.2005.10.006
10. Schaetti C, Ali SM, Chaignat C-L, Khatib AM, Hutubessy R, Weiss MG. Improving community coverage of oral cholera mass vaccination campaigns: lessons learned in Zanzibar. PLoS ONE. 2012;7:e41527. http://dx.doi.org/10.1371/journal.pone.0041527
11. Khan IA, Saha A, Chowdhury F, Khan AI, Uddin MJ, Begum YA, et al. Coverage and cost of a large oral cholera vaccination program in a high-risk cholera endemic urban population in Dhaka, Bangladesh. Vaccine. 2013;31:6058-64. http://dx.doi.org/10.1016/j.vaccine.2013.10.021
12. Ivers LC, Teng JE, Lascher J, Raymond M, Weigel J, Victor N, et al. Use of oral cholera vaccine in Haiti: a rural demonstration project. Am J Trop Med Hyg. 2013;89:617-24. http://dx.doi.org/10.4269/ajtmh.13-0183
13. Rouzier V, Severe K, Jean Juste MA, Peck M, Perodin C, Severe P, et al. Cholera vaccination in urban Haiti. Am J Trop Med Hyg. 2013;89:671-81. http://dx.doi.org/10.4269/ajtmh.13-0171
14. Kar SK, Sah B, Patnaik B, Kim YH, Kerketta AS, Shin S, et al. Mass vaccination with a new, less expensive oral cholera vaccine using public health infrastructure in India: the Odisha model. PLoS Negl Trop Dis. 2014;8:e2629. http://dx.doi.org/10.1371/journal.pntd.0002629
15. World Health Organization. Oral cholera vaccine campaign among internally displaced persons in South Sudan. Wkly Epidemiol Rec. 2014;89:214-20.
16. Calain P, Chaine J-P, Johnson E, Hawley M-L, O’Leary MJ, Oshitani H, et al. Can oral cholera vaccination play a role in controlling a cholera outbreak? Vaccine. 2004;22:2444-51. http://dx.doi.org/10.1016/j.vaccine.2003.11.070
17. Anh DD, Lopez AL, Thiem VD, Grahek SL, Duong TN, Park JK, et al. Use of oral cholera vaccines in an outbreak in Vietnam: a case control study. PLoS Negl Trop Dis. 2011;5:e1006. http://dx.doi.org/10.1371/journal.pntd.0001006
18. Luquero FJ, Grout L, Ciglenecki I, Sakoba K, Traore B, Heile M, et al. First outbreak response using an oral cholera vaccine in Africa: vaccine coverage, acceptability and surveillance of adverse events, Guinea, 2012. PLoS Negl Trop Dis. 2013;7:e2465 http://dx.doi.org/10.1371/journal.pntd.0002465
19. Bhattacharya SK, Sur D, Ali M, Kanungo S, You YA, Manna B, et al. 5 year efficacy of a bivalent killed whole-cell oral cholera vaccine in Kolkata, India: a cluster-randomised, double-blind, placebo-controlled trial. Lancet Infect Dis. 2013;13:1050-6. http://dx.doi.org/10.1016/S1473-3099(13)70273-1
20. Luquero FJ, Grout L, Ciglenecki I, Sakoba K, Traore B, Heile M, et al. Use of Vibrio cholerae vaccine in an outbreak in Guinea. N Engl J Med. 2014;370:2111-20. http://dx.doi.org/10.1056/NEJMoa1312680
21. Barzilay EJ, Schaad N, Magloire R, Mung KS, Boncy J, Dahourou GA, et al. Cholera surveillance during the Haiti epidemic—the first two years. N Engl J Med. 2013;368:599-609. http://dx.doi.org/10.1056/NEJMoa1204927
22. Tohme RA, François J, Wannemuehler K, Magloire R, Danovaro-Holliday C, Flannery B, et al. Measles and rubella vaccination coverage in Haiti, 2012: progress towards verifying and challenges to maintaining measles and rubella elimination. Trop Med Int Health. 2014;19:1105-15. http://dx.doi.org/10.1111/tmi.12335
23. Rainey JJ, Danovaro-Holliday MC, Magloire R, Kananda G, Lee CE, Chamouillet H, et al. Haiti 2007-2008 national measles-rubella vaccination campaign: implications for rubella elimination. J Infect Dis. 2011;204(Suppl 2):S616-21. http://dx.doi.org/10.1093/infdis/jir488
24. Sur D, Lopez AL, Kanungo S, Paisley A, Manna B, Ali M, et al. Efficacy and safety of a modified killed-whole-cell oral cholera vaccine in India: an interim analysis of a cluster-randomised, double-blind, placebo-controlled trial. Lancet. 2009;374:1694-702. http://dx.doi.org/10.1016/S0140-6736(09)61297-6
25. Ali M, Sur D, You YA, Kanungo S, Sah B, Manna B, et al. Herd protection by a bivalent killed whole-cell oral cholera vaccine in the slums of Kolkata, India. Clin Infect Dis. 2013;56:1123-31. http://dx.doi.org/10.1093/cid/cit009
26. Longini IM, Nizam A, Ali M, Yunus M, Shenvi N, Clemens JD. Controlling endemic cholera with oral vaccines. PLoS Med. 2007;4:e336. http://dx.doi.org/10.1371/journal.pmed.0040336
27. Vu DT, Hossain MM, Son ND, Hoa NT, Rao MR, Canh DG, et al. Coverage and costs of mass immunization of an oral cholera vaccine in Vietnam. J Health Popul Nutr. 2003;21:304-8.
28. Schaetti C, Chaignat CL, Hutubessy R, Khatib AM, Ali SM, Schindler C, et al. Social and cultural determinants of anticipated acceptance of an oral cholera vaccine prior to a mass vaccination campaign in Zanzibar. Hum Vaccin. 2011;7:1299-308. http://dx.doi.org/10.4161/hv.7.12.18012
29. Aibana O, Franke M, Teng J, Hilaire J, Raymond M, Ivers LC. Cholera vaccination campaign contributes to improved knowledge regarding cholera and improved practice relevant to waterborne disease in rural Haiti. PLoS Negl Trop Dis. 2013;7:e2576. http://dx.doi.org/10.1371/journal.pntd.0002576
30. Martin S, Costa A, Perea W. Stockpiling oral cholera vaccine. Bull World Health Organ. 2012;90:714. http://dx.doi.org/10.2471/BLT.12.112433
31. Martin S, Lopez AL, Bellos A, Deen J, Ali M, Alberti K. Post-licensure deployment of oral cholera vaccines: a systematic review. Bull World Health Organ. 2014;92:881-93. http://dx.doi.org/10.2471/BLT.14.139949
32. Mengel MA. Cholera in Africa: new momentum in fighting an old problem. Trans R Soc Trop Med Hyg. 2014;108:391-2. http://dx.doi.org/10.1093/trstmh/tru077
33. Saha A, Chowdhury MI, Khanam F, Bhuiyan S, Chowdhury F, Khan AI, et al. Safety and immunogenicity study of a killed bivalent (O1 and O139) whole-cell oral cholera vaccine Shanchol, in Bangladeshi adults and children as young as 1 year of age. Vaccine. 2011;29:8285-92. http://dx.doi.org/10.1016/j.vaccine.2011.08.108